Display options
Cite
Yang F, Yu Y, Lei Q, et al. Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408]. Biomed Pharmacother. 2019;120:109511doi: 10.1016/j.biopha.2019.109511.
Yang, F., Yu, Y., Lei, Q., Zeng, A., Li, Y., Xie, Y., Ye, T., & Wei, Y. (2019). Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 120109511. https://doi.org/10.1016/j.biopha.2019.109511
Yang, Fangfang, et al. "Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408]." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 120 (2019): 109511. doi: https://doi.org/10.1016/j.biopha.2019.109511
Yang F, Yu Y, Lei Q, Zeng A, Li Y, Xie Y, Ye T, Wei Y. Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408]. Biomed Pharmacother. 2019 Dec;120:109511. doi: 10.1016/j.biopha.2019.109511. Epub 2019 Oct 16. PMID: 31629561.
Copy Download .nbib Format: NLM
Share it on

Biomed Pharmacother. 2019 Dec;120:109511. doi: 10.1016/j.biopha.2019.109511. Epub 2019 Oct 16.

Corrigendum to "Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro" [Biomed. Pharmacother. 69 (2015) 402-408].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Fangfang Yang, Yang Yu, Qian Lei, Anqi Zeng, Yali Li, Yongmei Xie, TingHong Ye, Yuquan Wei

Affiliations

  1. State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  2. Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei Province, China.
  3. State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China. Electronic address: [email protected].
  4. State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China. Electronic address: [email protected].

PMID: 31629561 DOI: 10.1016/j.biopha.2019.109511

[No abstract available.]

Publication Types